ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
TCHVG 2024 | TAVI Session IV
In May 2024, The Diagnostic and Therapeutic Center of Athens Hygeia organized the Transcatheter Heart Valves Greece 2024. The conference featured pivotal specialty insights from both local faculty and internationally renowned professionals. Watch for more TCHVG 2024 videos in the coming weeks.
At the Transcatheter Heart Valves Greece 2024 conference, leading surgeons delivered presentations on various aspects of TAVI. Michael Borger addressed “The Crucial Role for Surgeons in TAVI,” reviewing the heart team concept and TAVI implantation rates. V. Androutsopoulou focused on “Failed Bioprosthetic Aortic Valve: Reoperation vs TAVI,” exploring sutureless biological aortic valve replacement and valve-in-valve transcatheter aortic valve replacement. Teoman Kilic presented “Aortic Valve Stenosis Treatment Options in Young and Low-Risk Patients,” highlighting the lessons learned from old generation devices and the risk scoring system for TAVI. Gregory Pattakos discussed “TAVI or SAVR for the Small Aortic Annulus,” examining aortic root enlargement and implications for future valve-in-valve procedure.
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
Printer-friendly
